Enterome raises $19M in funding to advance its Phase 1/2 trial of EO2463 OncoMimics for treating indolent non-Hodgkin lymphoma.
Amount Raised
$19 Million
Round Type
Funding Round
Description
Enterome, a Paris-based clinical-stage company, raised $19M in funding. The company intends to use the funds to advance its Phase 1/2 trial of EO2463 OncoMimics. This treatment targets multiple forms of indolent non-Hodgkin lymphoma. Led by CEO Pierre Bélichard, Enterome focuses on innovative immunotherapies for cancer.
Quick answer
Enterome raised $19 Million in a Funding Round round, dated June 12, 2025. Enterome is based in Paris, Ile-de-France, France.
- How much did Enterome raise?
- Enterome raised $19 Million in a Funding Round round on June 12, 2025.
- What does Enterome do?
- Enterome is a clinical-stage biopharmaceutical company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases.
- Where is Enterome based and how big is it?
- Enterome is based in Paris, Ile-de-France, France.
- Who are the decision-makers at Enterome?
- Fundz holds 1 contact at Enterome. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Enterome that raised within 45 days of this round, from Fundz verified event records.
- BioSapien raised $8M (Pre-Series A) on July 7, 2025.
- Pelthos Therapeutics raised $50M on July 1, 2025.
- Biofrontera raised $11M on June 27, 2025.
- Os Therapies raised $4.2M on June 23, 2025.
- Acurx Pharmaceuticals raised $4M (Seed) on June 17, 2025.
- Ensho Therapeutics raised $23M on June 12, 2025.
Who to call at Enterome, and when
A new round usually means Enterome is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Enterome raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Enterome, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Enterome. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Enterome raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Enterome raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.